Explore our blog
Tariffs, Supply Chains, and Drug Pricing: What Biopharma Should Be Watching
Dan Danielson, MS, R.Ph. | Senior Director, Access Experience Team Greg Gregory, PhD | Executive VP, Partner
Impact of Proposed Medicaid Cuts on Health Care Stakeholders
March 12, 2025 | Cynthia Miller, MD, MPH, FACP – VP, Medical Director, Access Experience Team
Medicare Advantage: 2025 and Beyond
April 3, 2025 | Maureen Hennessey, PhD, CPCC, CPHQ